Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Lipoedema
ADR ID BADD_A06215
ADR Hierarchy
14      Metabolism and nutrition disorders
14.08      Lipid metabolism disorders
14.08.04      Lipid metabolism and deposit disorders NEC
14.08.04.021      Lipoedema
Description Disorder of adipose tissue characterized by symmetric and bilateral enlargement of the lower extremities due to abnormal deposition of SUBCUTANEOUS FAT often in obese women. It is associated with HEMATOMA, pain and may progress to secondary LYMPHEDEMA which is known as lipolymphedema. | Lipedema with secondary LYMPHEDEMA involvement. [MeSH]
MedDRA Code 10063955
MeSH ID D065134
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Lipoedema | Lipedema | Lipo-lymphedema | Lipo-lymphoedema | Lipedemas | Lipoedemas | Lipolymphedema | Lipolymphedemas
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00228Benazepril hydrochloride--
BADD_D00589Dasatinib--
BADD_D00603Delavirdine--
BADD_D00932Fluoxetine0.000020%
BADD_D01281Levonorgestrel0.000946%
BADD_D01475Mirabegron--
BADD_D01653Paclitaxel0.000168%
BADD_D01974Rotigotine hydrochloride--
The 1th Page    1    Total 1 Pages